Major Research Achievements in Our History
1982 – Jeffrey Blumer, MD, establishes the hospital’s Center for Drug Research –one of the nation’s first pediatric clinical pharmacology and basic research programs.
1990 – Two children receive revolutionary gene therapy for an immune deficiency disorder at UH Rainbow Babies & Children’s Hospital – the first in the world.
1991-1994 – Hospital physicians participate in a national clinical study which demonstrates that hydroxyurea is an effective drug in preventing painful episodes of sickle cell disease.
1995 – Hospital physician performs the region’s first bone marrow transplant using umbilical cord blood.
1996 – Pediatric neurosurgeons help develop miniaturized tools for performing endoscopic brain surgery, reducing the need for open-skull surgery.
1999 – The hospital launches the Center for Bloodless Medicine and Surgery, becoming the first freestanding pediatric hospital in the nation to develop a bloodless program for children.
2011 – The Char and Chuck Fowler Family Foundation donates a $17 million transformational gift to establish the Angie Fowler Adolescent & Young Adult Cancer Institute at UH Rainbow Babies & Children’s Hospital.
2013 – Michele Walsh, MD, MS, leads pediatric efforts of the Ohio Perinatal Quality Collaborative to improve care and outcomes in Ohio by reducing bloodstream infections in hospitalized premature infants and near-term deliveries without medical indications. These efforts have reduced infections and NICU admissions, saving Ohio at least $11 million annually.
2016 – Angie’s Garden - a 7,500 sq. foot healing garden for patients, parents and staff - opens on the rooftop of UH Rainbow Babies & Children’s Hospital.
2017 – MedPacto partners with UH for first IO trial
2018 – Celloram spins-off DC technology (Letterio lab)
2019 – TheraCanVac signs agreement with Celloram; Almac to manufacture neo-antigen peptides